Humacyte, Inc. (HUMA) stock
HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.56−0.04 (-6.21%)
Close on Nov 13, 2026Market cap $155.12MP/E –Yield –
Humacyte market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Humacyte's market cap was $164.37M on Nov 11, 2026, against $214.43M a year earlier. Over the last 5 years it ranged from $114.23M to $1.13B, with a median of $330.64M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $164.37M | +7.7% |
| 2025 | Dec 31, 2025 | $152.56M | -74.8% |
| 2024 | Dec 31, 2024 | $605.21M | +106.0% |
| 2023 | Dec 29, 2023 | $293.83M | +35.1% |
| 2022 | Dec 30, 2022 | $217.54M | -70.9% |
| 2021 | Dec 31, 2021 | $746.77M | – |
See a number that looks wrong?